H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT

被引:296
作者
Ma, Chenchao [1 ]
Nong, Kate [1 ]
Zhu, Hongda [1 ]
Wang, Weiwei [1 ]
Huang, Xinyu [1 ]
Yuan, Zhou [1 ]
Ai, Kaixing [1 ]
机构
[1] Shanghai Jiao Tong Univ, People Hosp 6, Dept Gen Surg, Shanghai 200030, Peoples R China
关键词
LncRNA-H19; let-7; HMGA2; Pancreatic cancer; Migration; Invasion; TO-MESENCHYMAL TRANSITION; LONG NONCODING RNAS; BLADDER-CANCER; EXPRESSION; HMGA2; CELLS; GENE; GROWTH; MICRORNAS; LOCUS;
D O I
10.1007/s13277-014-2185-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The long noncoding RNA (lncRNA) H19 has been recently characterized as an oncogenic lncRNA in some tumors. However, the role of H19 in pancreatic ductal adenocarcinoma (PDAC) remains unclear. In this study, we found that not only the levels of H19 was overexpressed in PDAC compared with adjacent normal tissues, but also H19 expression was upregulated remarkably in primary tumors which subsequently metastasized, compared to those did not metastasis. Subsequently, the efficacy of knockdown of H19 by H19-small interfering RNA (siRNA) was evaluated in vitro, and we found that downregulation of H19 impaired PDAC cell invasion and migration. We further demonstrated that H19 promoted PDAC cell invasion and migration at least partially by increasing HMGA2-mediated epithelial-mesenchymal transition (EMT) through antagonizing let-7. This study suggests an important role of H19 in regulating metastasis of PDAC and provides some clues for elucidating the lncRNA-miRNA functional network in cancer.
引用
收藏
页码:9163 / 9169
页数:7
相关论文
共 44 条
  • [1] Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma
    Ariel, I
    Miao, HQ
    Ji, XR
    Schneider, T
    Roll, D
    de Groot, N
    Hochberg, A
    Ayesh, S
    [J]. JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY, 1998, 51 (01): : 21 - 25
  • [2] Belge G, 2011, HISTOL HISTOPATHOL, V26, P1029, DOI 10.14670/HH-26.1029
  • [3] let-7 microRNAs in development, stem cells and cancer
    Buessing, Ingo
    Slack, Frank J.
    Grosshans, Helge
    [J]. TRENDS IN MOLECULAR MEDICINE, 2008, 14 (09) : 400 - 409
  • [4] Examination of IGF2 and H19 loss of imprinting in bladder cancer
    Byun, Hyang-Min
    Wong, Hui-Lee
    Birnstein, Elliott Aaron
    Wolff, Erika M.
    Liang, Gangning
    Yang, Allen S.
    [J]. CANCER RESEARCH, 2007, 67 (22) : 10753 - 10758
  • [5] The imprinted H19 noncoding RNA is a primary microRNA precursor
    Cai, Xuezhong
    Cullen, Bryan R.
    [J]. RNA, 2007, 13 (03) : 313 - 316
  • [6] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866
  • [7] Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma
    Casola, S
    Pedone, PV
    Cavazzana, AO
    Basso, G
    Luksch, R
    dAmore, ESG
    Carli, M
    Bruni, CB
    Riccio, A
    [J]. ONCOGENE, 1997, 14 (12) : 1503 - 1510
  • [8] A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
    Cesana, Marcella
    Cacchiarelli, Davide
    Legnini, Ivano
    Santini, Tiziana
    Sthandier, Olga
    Chinappi, Mauro
    Tramontano, Anna
    Bozzoni, Irene
    [J]. CELL, 2011, 147 (02) : 358 - 369
  • [9] OncomiRs: the discovery and progress of microRNAs in cancers
    Cho, William C. S.
    [J]. MOLECULAR CANCER, 2007, 6 (1)
  • [10] The H19 locus: Role of an imprinted non-coding RNA in growth and development
    Gabory, Anne
    Jammes, Helene
    Dandolo, Luisa
    [J]. BIOESSAYS, 2010, 32 (06) : 473 - 480